Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo. - Wikidata - wikimedia - TriplyDB

Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.

Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.

http://www.wikidata.org/entity/Q30480100

about

Agents for inhibiting the adhesion of red blood cells to the endothelium in people with sickle cell disease Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response MEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivo Biomarkers and recent advances in the management and therapy of sickle cell disease Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3.Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease Sickle red cell-endothelium interactions.Restoration of intracellular ATP production in banked red blood cells improves inducible ATP export and suppresses RBC-endothelial adhesion.A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia.Impaired adenosine-5'-triphosphate release from red blood cells promotes their adhesion to endothelial cells: a mechanism of hypoxemia after transfusion.Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.Identification of signalling cascades involved in red blood cell shrinkage and vesiculation.Microfluidic study of enhanced deposition of sickle cells at acute corners.Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium.Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation The association of optimism and perceived discrimination with health care utilization in adults with sickle cell disease.Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium Effect of propranolol as antiadhesive therapy in sickle cell disease.Asthma management in sickle cell disease Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.Association between alcohol-induced erythrocyte membrane alterations and hemolysis in chronic alcoholics.Factors associated with survival in a contemporary adult sickle cell disease cohort.Novel therapies targeting the endothelium in sickle cell disease.Investigational selectin-targeted therapy of sickle cell disease.Emerging drugs for sickle cell anemia.Adenylyl Cyclase 9 Polymorphisms Reveal Potential Link to HDL Function and Cardiovascular Events in Multiple Pathologies: Potential Implications in Sickle Cell Disease.Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.Emerging point-of-care technologies for sickle cell disease screening and monitoring.Biomechanics and biorheology of red blood cells in sickle cell anemia.Epinephrine modulates BCAM/Lu and ICAM-4 expression on the sickle cell trait red blood cell membrane beta(2)-Adrenergic receptor and adenylate cyclase gene polymorphisms affect sickle red cell adhesion.Developing new pharmacotherapeutic approaches to treating sickle-cell disease.Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion.Acute gastrointestinal vaso-occlusive ischemia in sickle cell disease: CT imaging features and clinical outcome.

P2860

Q24188211-85B8025E-ED21-48A2-B598-9D8F76EE74FA Q26742061-DAAA219A-98A3-4E05-9FE4-9C028F907C74 Q27303155-3C4DC6E2-8BA2-4ACC-9801-EDC7F69AF3CC Q27324518-C2B3A610-873D-4AEF-A5F4-3677032B6409 Q27335195-C8309E0D-B81D-4677-84B9-DC86C35CEFAD Q28082462-071296A9-1A2A-4BC9-823A-2251B493BA77 Q28540243-F1CF2E34-C427-4DFD-ACD5-BC44CAD69FA2 Q30501007-35815BEE-420D-493A-BFDC-C7A00BFD249D Q33676406-984AAE69-478C-4131-9AD5-1CC15EF123C6 Q33791764-73E7B1B5-6E90-4AB4-9B95-27766B2E524B Q34255075-BAB17511-2CE0-4A9F-91D6-6133352BA99E Q34686539-D4B362C1-340B-4722-8427-A8EEFDB50913 Q34726945-2C3A6345-B956-4039-8911-C7BD7E7A9F8D Q34796372-E4E913F2-76FE-4BD0-BDCA-DF46D17BDEDC Q35388882-1EC8571A-6FE1-4D39-9B48-2CCA98C33D93 Q35533604-E753948C-6FC7-4F21-88F2-5E59C3F242B3 Q35574674-1BA99171-960A-40EC-AFC6-C2F9C6F18882 Q35688344-56DB2ED0-0983-4323-9F91-C9394E0B4891 Q35750346-5E052BBD-C205-4A11-9C2C-FDB00BEA33F4 Q35987429-8BE3F3C6-3CA6-4D19-8D35-C26ED72838CB Q36572034-B0BA5B4D-34DA-476F-8C49-B0D7D8B8E9DA Q36872388-491BEC5E-7DB5-44F3-9721-00F490899098 Q36941118-EA4397E4-D4B5-43D2-86E7-26A9FFC9B2B3 Q37146392-6C1DBDEA-F90A-4136-84EE-C1478B7714C7 Q37346672-B35908E4-A477-4E74-8CF0-5AB6219F1F5F Q37370659-2186DF9F-3327-4251-8A83-3C527D8A0D4B Q37614477-A0A666ED-6C81-448C-9637-B874046529D8 Q37705175-577C6A69-C6A2-45CC-BCFC-1755A6E803C1 Q37930655-193B06C5-FDC7-4AAA-93B2-4AF61259409D Q38253064-39C5D50B-4FF7-4B7F-A8B0-B1853D532238 Q38272226-D0ACF738-298B-4F96-B0EF-C3ABE4A2F967 Q38653425-79A44DBF-BE74-49E3-99BB-A8DF86B10FDF Q38760096-7F088A61-5828-4CAB-B66E-236FBBFE3DE6 Q38804432-E40DD41E-AB39-4A35-B377-7EEF9B617F64 Q39017039-EDCFB8D7-E89B-41FF-AD6B-4C526A93DB4C Q42503214-86F30E8E-BAEE-4865-8B81-92B3445B23A0 Q46715121-2550C920-6359-4C20-90E9-9D5150BEF973 Q50207951-9FC7A377-7C54-4D1C-BBF5-3324E3BEBCAF Q50230368-D1EC83DC-D64A-444D-89AE-2C5C8DDE69D2 Q52877179-C6565DAC-56C6-44AE-8111-5A6F4C4CB8EE

P2860

Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.

http://www.wikidata.org/entity/Q30480100

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Epinephrine-induced activation ...... on and vaso-occlusion in vivo.

@ast

Epinephrine-induced activation ...... on and vaso-occlusion in vivo.

@en

type

label

Epinephrine-induced activation ...... on and vaso-occlusion in vivo.

@ast

Epinephrine-induced activation ...... on and vaso-occlusion in vivo.

@en

prefLabel

Epinephrine-induced activation ...... on and vaso-occlusion in vivo.

@ast

Epinephrine-induced activation ...... on and vaso-occlusion in vivo.

@en

P1433

Q30480100-6B63F911-8D01-4760-839F-531377B466AA

P1476

Q30480100-0DA75672-39C7-4890-B9F8-D993BA2A8788

P2093

Q30480100-00779F75-2B29-4CD0-9CD7-7156CF62C42B

Q30480100-2C4FBE25-BE63-4417-8E18-A45FCF52564D

Q30480100-4E2510F5-3EBC-4B1D-AB98-D90E9F91BB49

Q30480100-6931BA2A-14EE-4F52-AAD4-AECC37B1BE6E

Q30480100-BB108729-92A9-4A38-B5DC-059332AFF92C

Q30480100-CCB054C0-EB5C-4074-B0A7-FB9E12E45994

Q30480100-D795FC41-E700-4958-BA42-80EEFE8B9F59

Q30480100-D88AB2BA-0D14-4399-84FF-A877D0EBC46E

Q30480100-DB47D4AB-714B-4FAB-A598-3FE35353E9D4

P2860

Q30480100-0527A4FF-2EDA-4679-BFBB-3BF566D26298

Q30480100-07CA4E11-2BED-43A1-990E-9A0FFFA72438

Q30480100-0933D8EA-CA59-4E91-890D-DC743EB6ACD9

Q30480100-0ADAC8BA-C1D2-4A59-84EE-928242CC4C0F

Q30480100-0E0EC557-3267-4E07-8B95-AA994CCE2BC8

Q30480100-1198A031-5AA4-4D83-BE4F-3BB6BF1A11D3

Q30480100-1BEC1480-2D64-496D-9861-09018506C538

Q30480100-1CF4CF67-51DD-4C75-963E-0A1EC5F3D47F

Q30480100-207DC72A-7795-41D4-B0C3-8C03BB54D89C

Q30480100-20D3414F-53F9-4806-AA0C-1C4B22629AD9

P304

Q30480100-3B9F74C6-48BE-4514-A75F-CC0EBC119BDB

P31

Q30480100-C80A66F8-D2FA-464C-A8BC-5F902546D31F

P356

Q30480100-6DB7756E-259F-4FDA-A789-10013D5DCB5A

P407

Q30480100-D785362C-2C48-4A62-9143-7365937B6A79

P433

Q30480100-2C64AAEC-AB66-46B5-A818-31E611DECB0E

P478

Q30480100-E4CFA1D0-CC72-4D97-A5E5-F2E6BC49E782

P577

Q30480100-1260CCCD-12DB-43F8-A5DD-C8388B963498

P5875

Q30480100-C5675F99-D56A-4C2B-9FFC-9061967E6B33

P698

Q30480100-70349479-E439-4FC1-A66F-2F66C5BFB61E

P921

Q30480100-2788AA68-3371-4EC7-96D0-314513533FA6

P932

Q30480100-195C0409-A6F2-49AD-B3F3-EB7E10C79A72

P356

BLOOD-2006-11-056101

P1433

P1476

Epinephrine-induced activation ...... on and vaso-occlusion in vivo.

@en

P2093

Benjamin J Moeller

http://www.w3.org/2001/XMLSchema#string

Erin J Whalen

http://www.w3.org/2001/XMLSchema#string

Ke Xu

http://www.w3.org/2001/XMLSchema#string

Marilyn J Telen

http://www.w3.org/2001/XMLSchema#string

Mark W Dewhirst

http://www.w3.org/2001/XMLSchema#string

Martha Delahunty

http://www.w3.org/2001/XMLSchema#string

Milena Batchvarova

http://www.w3.org/2001/XMLSchema#string

Rahima Zennadi

http://www.w3.org/2001/XMLSchema#string

Siqing Shan

http://www.w3.org/2001/XMLSchema#string

P2860

The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins

Rh-related antigen CD47 is the signal-transducer integrin-associated protein

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity

Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm

Serial in vivo observations of cerebral vasculature after treatment with a large single fraction of radiation.

Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications.

Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization.

The LW blood group glycoprotein is homologous to intercellular adhesion molecules

Intravital fluorescence facilitates measurement of multiple physiologic functions and gene expression in tumors of live animals

P304

2708-2717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2006-11-056101

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6229176

http://www.w3.org/2001/XMLSchema#string

P698

17609430

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

1988948

http://www.w3.org/2001/XMLSchema#string